Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Single Blind, Parallel Group, Placebo Controlled, Multidose Study Comparing the Therapeutic Equivalence of a 3M Budesonide/Formoterol Fumarate Inhaler and a Symbicort® Reference Inhaler in Adult Subjects With Asthma

NCT03015259 is registered in ClinicalTrials.gov with Kindeva Drug Delivery as lead sponsor.

NCT NCT03015259
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03015259 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Single Blind, Parallel Group, Placebo Controlled, Multidose Study Comparing the Therapeutic Equivalence of a 3M Budesonide/Formoterol Fumarate Inhaler and a Symbicort® Reference Inhaler in Adult Subjects With Asthma
Lead sponsor
Kindeva Drug Delivery
Phase
Phase 3
Overall status
Completed
Start date
December 29, 2016
Completion date
February 8, 2018
Enrollment
1,762 (actual)
Sites
95

Conditions

As the registry lists them; a condition with its own page is linked.

asthma